Naltrexone in Borderline Personality Disorder

Clinical trial NCT00124839 · TERMINATED

Trial details

NCT number: NCT00124839
Sponsor: Central Institute of Mental Health, Mannheim
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Borderline Personality Disorder

Start date: 2005-10-01
Primary completion: 2007-10-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.